Penn Medicine Provider
Pulmonary Medicine
Steven M. Kawut, MD, MS
4.9
(84)
Accepting new patients
Sees patients age 18 and up
Harron Lung Center Perelman
View 2 additional locations
Schedule onlineCall 215-615-5864

About me

  • Director, Pulmonary Hypertension/Pulmonary Vascular Disease Program
  • Professor of Medicine (Pulmonary, Allergy and Critical Care)
  • Professor of Medicine in Biostatistics and Epidemiology

Education and training

  • Medical School: Yale University
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
4.9

84 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
easy to relate to
April 2025
2.0
2.0
i felt the referrals were too numerous, some inclusions on report a surprise when later read. conversation pleasant. conclusions a blow.
March 2025
5.0
5.0
never rushes.
March 2025
5.0
5.0
went smoothly

Insurance accepted

My Locations

Learn about location
Learn about location
Learn about location

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Penn Medicine Rittenhouse Long-Term Acute Care Hospital
Dr. Kawut is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Ventetuolo CE, Praestgaard A, Palevsky HI, Klinger JR, Halpern SD, Kawut SM Sex and hemodynamics in pulmonary arterial hypertension , Eur Respir J, 43(2): 2014,523-30

Goncharov DA, Kudryashova TV, Ziai H, Ihida-Stansbury K, DeLisser H, Krymskaya VP, Tuder RM, Kawut SM, Goncharova EA. mTORC2 coordinates pulmonary artery smooth muscle cell metabolism, proliferation and survival in pulmonary arterial hypertension , Circulation, 129(8): 2014,864-74

Whitman I, Patel VV, Soliman EZ, Bluemke DA, Praestgaard A, Jain A, Herrington D, Lima JAC, Kawut SM Validity of the surface electrocardiogram criteria for right ventricular hypertrophy: The MESA - Right Ventricle Study , JACC: 2014,5435

Smith BM, Kawut SM, Bluemke DA, Basner RC, Gomes AS, Hoffman E, Kalhan R, Lima JAC, Liu C-Y, Michos ED, Prince MR, Rabbani L, Rabinowitz D, Shimbo D, Shea S, Barr RG Pulmonary hyperinflation and left ventricular mass: The Multi-Ethic Study of Atherosclerosis COPD Study , Circulation, 127(14): 2013,1503-11

Grau M, Graham Barr R, Lima JA, Hoffman EA, Bluemke DA, Carr JJ, Chahal H, Enright PL, Jain A, Prince MR, Kawut SM Percent emphysema and right ventricular structure and function: The MESA Lung and MESA-RV Studies , Chest, 144(1): 2013,136-44

Fritz J, Blair C, Oudiz R, Dufton C, Olschewski H, Despain D, Gillies H, Kawut SM Baseline and follow-up six minute walk distance and BNP predict 2-year mortalilty in pulmonary arterial hypertension , Chest, 143(2): 2013,315-23

Kawut SM, Barr RG, Lima JA, Praestgaard A, Johnson WC, Chahal H, Ogunyankin KO, Bristow MR, Kizer JR, Tandri H, Bluemke DA. Right ventricular structure is associated with the risk of heart failure and cardiovascular death: The MESA-Right Ventricle Study , Circulation, 126(14): 2012,1681-8

Gabler NB, French B, Strom BL, Liu Z, Palevsky HI, Taichman DB, Kawut, SM, Halpern SD Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension , Chest, 141(1): 2012,20-6

Gabler NM, French B, Strom BL, Palevsky HI, Taichman DB, Kawut SM, Halpern SD Validation of 6-minute walk distance as a surrogate end point in pulmonary arterial hypertension trials , Circulation, 126(3): 2012,349-56

View all publications